Commentary
Multiparametric MRI is a promising technique to assess hepatic steatosis, inflammation, and fibrosis, potentially enabling non-invasive identification of individuals with active and advanced stages of NAFLD.
The aim of the current proof-of-principle study by M. A. Troelstra et al. (Amsterdam University Medical Centres, The Netherlands) was to assess the use of multi- parametric MRI and determine the best-performing imaging parameters for identifying the full NAFLD disease spectrum in a subgroup of the Amsterdam NAFLD-NASH cohort.
Overall, the results indicate that multiparametric MRI is a promising non-invasive method for the accurate assessment of steatosis and fibrosis severity, as well as ballooning. This technique appears to have the potential to distinguish between simple hepatic steatosis and NASH.
Hepatic inflammatory responses in liver fibrosis